In contrast, it has been reported that in adolescents with MDD, responders showed a significant decrease in BDNF levels at week two of Selective Serotonin Reuptake Inhibitor (SSRI) treatment, compared to non-responders whose levels remained unchanged until that time [41]. Here, BDNF is linked to major depressive disorder.